Table 4 Subsequent regimens in case a stavudine containing regimen was substituted with another first line combination
From: cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011
2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|
(n = 18) | (n = 46) | (n = 66) | (n = 69) | (n = 43) | |
AZT/3TC/NVP | 2 (11.1%) | 22 (47.8) | 23 (34.8%) | 32 (46.4%) | 18 (41.9%) |
AZT/3TC/EFV | 16 (88.9%) | 24 (52.2%) | 30 (45.5%) | 6 (8.7%) | 3 (7%) |
TDF/FTC/EFV | 0 | 0 | 13 (19.7%) | 31 (44.9%) | 22 (51.1%) |